Oxytocin and social cognition in patients with schizophrenia: comparison with healthy siblings and healthy controls

References

• Olsson A, Ochsner KN. The role of social cognition in emotion. Trends Cogn Sci. 2008;12(2):65–71. doi: 10.1016/j.tics.2007.11.010
   PubMed Web of Science ®Google Scholar
• Fett A-KJ, Viechtbauer W, Penn DL, et al. The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neurosci Bıobehav Rev. 2011;35(3):573–588. doi: 10.1016/j.neubiorev.2010.07.001
   PubMed Web of Science ®Google Scholar
• Fenton WS, McGlashan TH. Natural history of schizophrenia subtypes: II. Positive and negative symptoms and long-term course. Arch Gen Psychiat. 1991;48(11):978–986. doi: 10.1001/archpsyc.1991.01810350018003
   PubMed Web of Science ®Google Scholar
• Mueser KT MS. Schizophrenia. The Lancet (London, England). 2004;363:2063–2072. doi: 10.1016/S0140-6736(04)16458-1
   PubMed Web of Science ®Google Scholar
• Andreasen N. Symptoms, signs, and diagnosis of schizophrenia. The Lancet (London, England). 1995;346(8973):477–481. doi: 10.1016/S0140-6736(95)91325-4
   Web of Science ®Google Scholar
• Alves F dS, Figee M, van Amelsvoort T, et al. The revised dopamine hypothesis of schizophrenia: evidence from pharmacological MRI studies with atypical antipsychotic medication. Schizophr Res. 2008;102(1):96–97. doi: 10.1016/S0920-9964(08)70291-3
   Google Scholar
• LaCrosse A L, Foster Olive M. Neuropeptide systems and schizophrenia. CNS Neurol Disord Drug Targets. 2013;12(5):619–632. doi: 10.2174/1871527311312050010
   Web of Science ®Google Scholar
• Foster DJ CD, Conn PJ, Rook JM. Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer’s disease and schizophrenia. Neuropsych Dis Treat. 2014;10:183–191.
   Web of Science ®Google Scholar
• Bujanow W. Letter: is oxytocin an anti-schizophrenic hormone? Can Psychiat Ass J. 1974;19(3):323.
   Google Scholar
• Beckmann H, Lang RE, Gattaz WF. Vasopressin-oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls. Psychoneuroendocrinology. 1985;10(2):187–191. doi: 10.1016/0306-4530(85)90056-3
   PubMed Web of Science ®Google Scholar
• Legros J, Gazzotti C, Carvelli T, Franchimont P, Timsit-Berthier M, Von Frenckell R, et al. Apomorphine stimulation of vasopressin-and oxytocin-neurophysins: evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenics. Psychoneuroendocrinology. 1992;17(6):611–617. doi: 10.1016/0306-4530(92)90019-4
   Web of Science ®Google Scholar
• Linkowski P, Geenen V, Kerkhofs M, et al. Cerebrospinal fluid neurophysins in affective illness and in schizophrenia. Eur Arch Psychiatry Neurol Sci. 1984;234(3):162–165. doi: 10.1007/BF00461555
   Google Scholar
• Glovinsky D, Kalogeras KT, Kirch DG, et al. Cerebrospinal fluid oxytocin concentration in schizophrenic patients does not differ from control subjects and is not changed by neuroleptic medication. Schizophr Res. 1994;11(3):273–276. doi: 10.1016/0920-9964(94)90021-3
   Web of Science ®Google Scholar
• Goldman M, Marlow-O’Connor M, Torres I, et al. Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits. Schizophr Res. 2008;98(1):247–255. doi: 10.1016/j.schres.2007.09.019
   Web of Science ®Google Scholar
• Kéri S, Kiss I, Kelemen O. Sharing secrets: oxytocin and trust in schizophrenia. Soc Neurosci. 2008;4(4):287–293. doi: 10.1080/17470910802319710
   Web of Science ®Google Scholar
• Quintana DS, Woolley JD. Intranasal oxytocin mechanisms can be better understood, but its effects on social cognition and behavior are not to be sniffed at. Biol Psychiatry. 2016;79(8):e49–e50. doi: 10.1016/j.biopsych.2015.06.021
   Web of Science ®Google Scholar
• Davis MC, Lee J, Horan WP, Clarke AD, McGee MR, Green MF, et al. Effects of single dose intranasal oxytocin on social cognition in schizophrenia. Schizophr Res. 2013;147(2):393–397. doi: 10.1016/j.schres.2013.04.023
   Web of Science ®Google Scholar
• Woolley J, Chuang B, Lam O, Lai W, O’Donovan A, Rankin K, et al. Oxytocin administration enhances controlled social cognition in patients with schizophrenia. Psychoneuroendocrinology. 2014;47:116–125. doi: 10.1016/j.psyneuen.2014.04.024
   PubMed Web of Science ®Google Scholar
• Weisman O, Zagoory-Sharon O, Feldman R. Oxytocin administration to parent enhances infant physiological and behavioral readiness for social engagement. Biol Psychiat. 2012;72(12):982–989. doi: 10.1016/j.biopsych.2012.06.011
   PubMed Web of Science ®Google Scholar
• Lerer E, Levi S, Salomon S, et al. Association between the oxytocin receptor (OXTR) gene and autism: relationship to vineland adaptive behavior scales and cognition. Mol Psychiat. 2008;13(10):980–988. doi: 10.1038/sj.mp.4002087
   PubMed Web of Science ®Google Scholar
• First MB, Spitzer RL, Gibbon M, et al. Structural clinical interview for DSM-IV axis I disorders (SCID-IV). New York (NY) : Biometrics Research Department, New York State Psychiatric Institute; 1997.
   Google Scholar
• Kay SR, Flszbein A, Opfer LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261. doi: 10.1093/schbul/13.2.261
   PubMed Web of Science ®Google Scholar
• Heaton RK. Wisconsin card sorting test: computer version 2. Odessa: Psychological Assessment Resources; 1993.
   Google Scholar
• Baddeley A. Exploring the central executive. Q J Exp Physiol: A. 1996;49(1):5–28.
   Web of Science ®Google Scholar
• Barceló F, Knight RT. Both random and perseverative errors underlie WCST deficits in prefrontal patients. Neuropsychologia. 2002;40(3):349–356. doi: 10.1016/S0028-3932(01)00110-5
   PubMed Web of Science ®Google Scholar
• Stuss DT, Levine B. Adult clinical neuropsychology: lessons from studies of the frontal lobes. Annu Rev Psychol. 2002;53(1):401–433. doi: 10.1146/annurev.psych.53.100901.135220
   PubMed Web of Science ®Google Scholar
• Butler M, Retzlaff PD, Vanderploeg R. Neuropsychological test usage. Professional Psychology: Research and Practice. 1991;22(6):510. doi: 10.1037/0735-7028.22.6.510
   Web of Science ®Google Scholar
• Wechsler D. Wechsler adult intelligence scale. 4th Ed. (WAIS–IV). San Antonio: NCS Pearson; 2008.
   Google Scholar
• Krull KR, Scott JG, Sherer M. Estimation of premorbid intelligence from combined performance and demographic variables. Clin Neuropsychol. 1995;9(1):83–88.
   Google Scholar
• Baron-Cohen S, Wheelwright S, Hill J, et al. The “Reading the Mind in the Eyes” Test revised version: a study with normal adults, and adults with Asperger syndrome or high-functioning autism. J Child Psychol Psychiatry. 2001;42(2):241–251. doi: 10.1111/1469-7610.00715
   PubMed Web of Science ®Google Scholar
• Yıldırım EA, Kasar M, Güdük M. Investigation of the reliability of the “Reading the Mind in the Eyes Test” in a Turkish population. Turk Psikiyatr Derg. 2011;22(3):177.
   PubMed Web of Science ®Google Scholar
• Craig JS, Hatton C, Craig FB, et al. Persecutory beliefs, attributions and theory of mind: comparison of patients with paranoid delusions, Asperger’s syndrome and healthy controls. Schizophr Res. 2004;69(1):29–33. doi: 10.1016/S0920-9964(03)00154-3
   PubMed Web of Science ®Google Scholar
• Broicher SH. On clinical diagnostics of social cognition in patients with epilepsies. Epileptologie. 2011;28:215–228.
   Google Scholar
• Szeto A, McCabe PM, Nation DA, Tabak BA, Rossetti MA, McCullough ME, et al. Evaluation of enzyme immunoassay and radioimmunoassay methods for the measurement of plasma oxytocin. Psychosom Med. 2011;73(5):393. doi: 10.1097/PSY.0b013e31821df0c2
   PubMed Web of Science ®Google Scholar
• Lawson EA H, Santin LM, Meenaghan M, et al. Oxytocin secretion is associated with severity of disordered eating psychopathology and insular cortex hypoactivation in anorexia nervosa. J Clin Endocrinol Metab. 2012;97(10):E1898–E1908. doi: 10.1210/jc.2012-1702
   Web of Science ®Google Scholar
• Brüne M, Ebert A, Kolb M, et al. Oxytocin influences avoidant reactions to social threat in adults with borderline personality disorder. Hum Psychopharm Clin. 2013;28(6):552–561. doi: 10.1002/hup.2343
   PubMed Web of Science ®Google Scholar
• Rubin LH, Carter CS, Drogos L, et al. Peripheral oxytocin is associated with reduced symptom severity in schizophrenia. Schizophr Res. 2010;124(1–3):13–21. doi: 10.1016/j.schres.2010.09.014
   Web of Science ®Google Scholar
• Garfield L, Giurgescu C, Carter CS, et al. Depressive symptoms in the second trimester relate to low oxytocin levels in African-American women: a pilot study. Arch Women Ment Hlth. 2015;18(1):123–129. doi: 10.1007/s00737-014-0437-4
   PubMed Web of Science ®Google Scholar
• Edwards J, Jackson HJ, Pattison PE. Emotion recognition via facial expression and affective prosody in schizophrenia: a methodological review. Clin Psychol Rev. 2002;22(6):789–832. doi: 10.1016/S0272-7358(02)00130-7
   PubMed Web of Science ®Google Scholar
• Trémeau F. A review of emotion deficits in schizophrenia. Dialogues Clin Neurosci. 2006;8(1):59–70.
   PubMedGoogle Scholar
• Perez-Rodriguez MM, Mahon K, Russo M, et al. Oxytocin and social cognition in affective and psychotic disorders. Eur Neuropsychopharm. 2015;25(2):265–282. doi: 10.1016/j.euroneuro.2014.07.012
   Web of Science ®Google Scholar
• Bediou B, Asri F, Brunelin J, Krolak-Salmon P, D’AMATO T, Saoud M, et al. Emotion recognition and genetic vulnerability to schizophrenia. Brit J Psychiat. 2007;191(2):126–130. doi: 10.1192/bjp.bp.106.028829
   Web of Science ®Google Scholar
• Kohler CG, Walker JB, Martin EA, et al. Facial emotion perception in schizophrenia: a meta-analytic review. Schizophrenia Bull. 2009;36(5):1009–1019. doi: 10.1093/schbul/sbn192
   Web of Science ®Google Scholar
• Eack SM, Mermon DE, Montrose DM, Miewald J, Gur RE, Gur RC, et al. Social cognition deficits among individuals at familial high risk for schizophrenia. Schizophrenia Bull. 2010;36(6):1081–1088. doi: 10.1093/schbul/sbp026
   Web of Science ®Google Scholar
• Brüne M. “Theory of mind” in schizophrenia: a review of the literature. Schizophrenia Bull. 2005;31(1):21–42. doi: 10.1093/schbul/sbi002
   PubMed Web of Science ®Google Scholar
• Bora E, Yucel M, Pantelis C. Theory of mind impairment in schizophrenia: meta-analysis. Schizophr Res. 2009;109(1):1–9. doi: 10.1016/j.schres.2008.12.020
   PubMed Web of Science ®Google Scholar
• Bora E, Gökçen S, Veznedaroglu B. Empathic abilities in people with schizophrenia. Psychiat Res. 2008;160(1):23–29. doi: 10.1016/j.psychres.2007.05.017
   Web of Science ®Google Scholar
• Bora E, Erkan A, Kayahan B, et al. Cognitive insight and acute psychosis in schizophrenia. Psychiat Clin Neurosci. 2007;61(6):634–639. doi: 10.1111/j.1440-1819.2007.01731.x
   Web of Science ®Google Scholar
• Bora E, Eryavuz A, Kayahan B, et al. Social functioning, theory of mind and neurocognition in outpatients with schizophrenia; mental state decoding may be a better predictor of social functioning than mental state reasoning. Psychiat Res. 2006;145(2):95–103. doi: 10.1016/j.psychres.2005.11.003
   Web of Science ®Google Scholar
• Sprong M, Schothorst P, Vos E, et al. Theory of mind in schizophrenia. Brit J Psychiat. 2007;191(1):5–13. doi: 10.1192/bjp.bp.107.035899
   PubMed Web of Science ®Google Scholar
• Heinrichs M, von Dawans B, Domes G. Oxytocin, vasopressin, and human social behavior. Front Neuroendocrinol. 2009;30(4):548–557. doi: 10.1016/j.yfrne.2009.05.005
   PubMed Web of Science ®Google Scholar
• Rubin LH, Carter CS, Drogos L, et al. Peripheral oxytocin is associated with reduced symptom severity in schizophrenia. Schizophr Res. 2010;124(1):13–21. doi: 10.1016/j.schres.2010.09.014
   Web of Science ®Google Scholar
• Pedersen CA, Gibson CM, Rau SW, Salimi K, Smedley KL, Casey RL, et al. Intranasal oxytocin reduces psychotic symptoms and improves theory of mind and social perception in schizophrenia. Schizophr Res. 2011;132(1):50–53. doi: 10.1016/j.schres.2011.07.027
   PubMed Web of Science ®Google Scholar
• Feifel D, Macdonald K, Nguyen A, Cobb P, Warlan H, Galangue B, et al. Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. Biol Psychiat. 2010;68(7):678–680. doi: 10.1016/j.biopsych.2010.04.039
   PubMed Web of Science ®Google Scholar
• Fischer-Shofty M, Shamay-Tsoory S, Harari H, et al. The effect of intranasal administration of oxytocin on fear recognition. Neuropsychologia. 2010;48(1):179–184. doi: 10.1016/j.neuropsychologia.2009.09.003
   PubMed Web of Science ®Google Scholar
• Walss-Bass C, Fernandes JM, Roberts DL, et al. Differential correlations between plasma oxytocin and social cognitive capacity and bias in schizophrenia. Schizophr Res. 2013;147(2):387–392. doi: 10.1016/j.schres.2013.04.003
   Web of Science ®Google Scholar
• Strauss GP, Keller WR, Koenig JI, et al. Plasma oxytocin levels predict olfactory identification and negative symptoms in individuals with schizophrenia. Schizophr Res. 2015;162(1):57–61. doi: 10.1016/j.schres.2014.12.023
   Web of Science ®Google Scholar
• Pinkham AE, Penn DL, Perkins DO, et al. Implications for the neural basis of social cognition for the study of schizophrenia. Am J Psychiat. 2003;160(5):815–824. doi: 10.1176/appi.ajp.160.5.815
   PubMed Web of Science ®Google Scholar
• Rosenfeld AJ, Lieberman JA, Jarskog LF. Oxytocin, dopamine, and the amygdala: a neurofunctional model of social cognitive deficits in schizophrenia. Schizophrenia Bull. 2010;37(5):1077–1087. doi: 10.1093/schbul/sbq015
   Web of Science ®Google Scholar
• Modahl C, Green LA, Fein D, Morris M, Waterhouse L, Feinstein C, et al. Plasma oxytocin levels in autistic children. Biol Psychiat. 1998;43(4):270–277. doi: 10.1016/S0006-3223(97)00439-3
   PubMed Web of Science ®Google Scholar
• Green L, Fein D, Modahl C, et al. Oxytocin and autistic disorder: alterations in peptide forms. Biol Psychiat. 2001;50(8):609–613. doi: 10.1016/S0006-3223(01)01139-8
   PubMed Web of Science ®Google Scholar
• Cochran D, Fallon D, Hill M, et al. The role of oxytocin in psychiatric disorders: a review of biological and therapeutic research findings. Harvard Rev Psychiat. 2013;21(5):219. doi: 10.1097/HRP.0b013e3182a75b7d
   PubMed Web of Science ®Google Scholar
• Evans SL, Dal Monte O, Noble P, et al. Intranasal oxytocin effects on social cognition: a critique. Brain Res. 2014;1580:69–77. doi: 10.1016/j.brainres.2013.11.008
   PubMed Web of Science ®Google Scholar